Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE — Mark T Gladwin (UNIVERSITY OF MARYLAND BALTIMORE)
As patients with sickle cell disease (SCD) live to adulthood, the chronic impact of sustained hemolytic anemia and episodic vaso-occlusive events take their toll, with the progressive development of c
| Project title | Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE |
|---|---|
| Project number | 5UH3HL143192-07 |
| PI name | Mark T Gladwin |
| Institution | UNIVERSITY OF MARYLAND BALTIMORE |
| Funding mechanism | UH3 |
| Agency | NHLBI |
| Award amount | $2.55M |
| Fiscal year | 2024 |
| Project start | 2022-09-01T00:00:00 |
| Project end | 2026-04-30T00:00:00 |
| Abstract | As patients with sickle cell disease (SCD) live to adulthood, the chronic impact of sustained hemolytic anemia and episodic vaso-occlusive events take their toll, with the progressive development of c |
| Key terms | <21+ years old><Accelerometer><Accident and Emergency department><Activities of Daily Living><Activi |
$799/mo
Try GrantRadar →